Dietary fish oil normalized glucose-stimulated insulin secretion in isolated pancreatic islets of dyslipemic rats through mechanisms involving glucose phosphorylation, peroxisome proliferator-activated receptor γ and uncoupling protein 2

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 89, Issue 1, 2013, Pages 31-38

  Ferreira, M R ^a   Chicco, A ^a   Lombardo, Y B ^a  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

Dyslipemic rats; Fish oil; Glucose stimulated insulin secretion; Pancreatic islets; PPARs; UCP2

Indexed keywords

CORN OIL; FISH OIL; GLUCOKINASE; GLUCOSE TRANSPORTER 2; HEXOKINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PYRUVATE DEHYDROGENASE; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME ACTIVITY; FAT CONTENT; FATTY ACID BLOOD LEVEL; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; INSULIN RELEASE; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; MALE; METABOLITE; NONHUMAN; PANCREAS ISLET; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION; TRANSCRIPTION REGULATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; DYSLIPIDEMIAS; FISH OILS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 2; INSULIN; ION CHANNELS; ISLETS OF LANGERHANS; MALE; MITOCHONDRIAL PROTEINS; PHOSPHORYLATION; PPAR GAMMA; RATS; RATS, WISTAR;

RATTUS; ZEA MAYS;

EID: 84878964883     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.04.006     Document Type: Article

References (45)

1. Poitut V., Robertson R.P. Glucolipotoxicity: fuel excess and β cell dysfunction. Endocr. Rev. 2008, 29:351-366.
2. Shimabukuro M., Zhou Y.T., Levi M., Unger R.H. Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. USA 1998, 95:2498-2502.
3. Morgan N.G. Fatty acids and beta-cell toxicity. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12:117-122.
4. Lombardo Y.B., Chicco A.G. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J. Nutr. Biochem. 2006, 17:1-13.
5. Calder P.C. Mechanisms of action of (n-3) fatty acids. J. Nutr. 2012, 142:592S-599S.
6. Hein G.J., Bernasconi A.M., Montanaro M.A., et al. Nuclear receptors and hepatic lipidogenic enzyme response to a dyslipidemic sucrose-rich diet and its reversal by fish oil n-3 polyunsaturated fatty acids. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E429-E439.
7. Storlien L.H., Kraegen E.W., Chisholm D.J., Ford G.L., Bruce D.G., Pascoe W.S. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987, 237:885-888.
8. Ghafoorunissa, Ibrahim A., Rajkumar L., Acharya V. Dietary (n-3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats. J. Nutr. 2005, 135:2634-2638.
9. Holness M.J., Smith N.D., Greenwood G.K., Sugden M.C. Acute ω-3 fatty acid enrichment selectively reverses high-saturated fat feeding-induced insulin hypersecretion but does not improve peripheral insulin resistance. Diabetes 2004, 53(Suppl 1):S166-S171.
10. Kato T., Shimano H., Yamamoto T., et al. Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets. Diabetes 2008, 57:2382-2392.
11. Wei D., Li J., Shen M., et al. Cellular production of n-3 PUFAs and reduction of n-6-to-n-3 ratios in the pancreatic β-cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death. Diabetes 2010, 59:471-478.
12. Ferreira M.R., Lombardo Y.B., Chicco A. β-Cell adaptation/dysfunction in an animal model of dyslipidemia and insulin resistance induced by the chronic administration of a sucrose-rich diet. Islets 2010, 2:367-373.
13. Pighin D., Karabatas L., Rossi A., Chicco A., Basabe J.C., Lombardo Y.B. Fish oil affects pancreatic fat storage, pyruvate dehydrogenase complex activity and insulin secretion in rats fed a sucrose-rich diet. J. Nutr. 2003, 133:4095-4101.
14. D'Alessandro M.E., Chicco A., Lombardo Y.B. Fish oil reverses the altered glucose transporter, phosphorylation, insulin receptor substrate-1 protein level and lipid contents in the skeletal muscle of sucrose-rich diet fed rats. Prostaglandins Leukot. Essent. Fatty Acids 2012, 88:171-177.
15. Laurell S. A method for routine determination of plasma triglycerides. Scand. J. Clin. Lab Invest. 1966, 18:668-672.
16. Duncombe W.G. The colorimetric micro-determination of long-chain fatty acids. Biochem. J. 1963, 88:7-10.
17. Bergmeyer H.U. Method for determination of metabolites. Methods of Enzymatic Analysis 1974, 1100-2110. Academic, New York. 2nd ed. H.U. Bergmeyer (Ed.).
18. Herbert V., Lau K.S., Gottlieb C.W., Bleicher S.J. Coated charcoal immunoassay of insulin. J. Clin. Endocrinol. Metab. 1965, 25:1375-1384.
19. Lacy P.E., Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967, 16:35-39.
20. Briaud I., Harmon J.S., Kelpe C.L., Segu V.B., Poitout V. Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 2001, 50:315-321.
21. Zhou Y.P., Berggren P.O., Grill V. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse. Diabetes 1996, 45:580-586.
22. Liang Y., Najafi H., Matschinsky F.M. Glucose regulates glucokinase activity in cultured islets from rat pancreas. J. Biol. Chem. 1990, 265:16863-16866.
23. Trus M.D., Zawalich W.S., Burch P.T., Berner D.K., Weill V.A., Matschinsky F.M. Regulation of glucose metabolism in pancreatic islets. Diabetes 1981, 30:911-922.
24. Shao J., Qiao L., Friedman J.E. Prolactin, progesterone, and dexamethasone coordinately and adversely regulate glucokinase and cAMP/PDE cascades in MIN6 beta-cells. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E304-E310.
25. Welters H.J., McBain S.C., Tadayyon M., Scarpello J.H., Smith S.A., Morgan N.G. Expression and functional activity of PPARγ in pancreatic β cells. Br. J. Pharmacol. 2004, 142:1162-1170.
26. Lameloise N., Muzzin P., Prentki M., Assimacopoulos-Jeannet F. Uncoupling protein 2: a possible link between fatty acid excess and impaired glucose-induced insulin secretion?. Diabetes 2001, 50:803-809.
27. Chicco A., D'Alessandro M.E., Karabatas L., Pastorale C., Basabe J.C., Lombardo Y.B. Muscle lipid metabolism and insulin secretion are altered in insulin-resistant rats fed a high sucrose diet. J. Nutr. 2003, 133:127-133.
28. Snedecor G.W.P., Cochran W.G. Factorial experiments. Statistical Methods Applied to Experimental Agriculture and Biology 1967, 339-350. Iowa State University Press. I.A. Ames (Ed.).
29. Selenscig D., Rossi A., Chicco A., Lombardo Y.B. Increased leptin storage with altered leptin secretion from adipocytes of rats with sucrose-induced dyslipidemia and insulin resistance: effect of dietary fish oil. Metabolism 2010, 59:787-795.
30. Perez-Martinez P., Perez-Gimenez F., Lopez-Miranda J. n-3 PUFA and lipotoxicity. Biochim. Biophys. Acta 2010, 1801:362-366.
31. Fedor D., Kelley D.S. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12:138-146.
32. Gremlich S., Bonny C., Waeber G., Thorens B. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J. Biol. Chem. 1997, 272:30261-30269.
33. Nascimento F.A., Barbosa-da-Silva S., Fernandes-Santos C., Mandarim-de-Lacerda C.A., Aguila M.B. Adipose tisuue, liver and pancreas structural alterations in C57BL/6 mice fed high-fat-high-sucrose diet supplemented with fish oil (n-3 fatty acid rich oil). Exp. Toxicol. Pathol. 2010, 62:17-25.
34. Takahashi A., Motomura K., Kato T., et al. Transgenic mice overexpressing nuclear SREBP-1c in pancreatic beta-cells. Diabetes 2005, 54:492-499.
35. Fatehi-Hassanabad Z., Chan C.B. Transcriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic β-cell function. Nutr. Metab. 2005, 2:1.
36. Chan C.B., Saleh M.C., Koshkin V., Wheeler M.B. Uncoupling protein 2 and islet function. Diabetes 2004, 53(Suppl 1):S136-S142.
37. Chan C.B., De Leo L.D., Joseph J.W., et al. Increased uncoupling protein-2 levels in β-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes 2001, 50:1302-1310.
38. Ito E., Ozawa S., Takahashi K., et al. PPAR-γ overexpression selectively suppresses insulin secretory capacity in isolated pancreatic islets through induction of UCP-2 protein. Biochem. Biophys. Res. Commun. 2004, 324:810-814. M.
39. Shimabukuro, Zhou Y.T., Lee Y., Unger R.H. Induction of uncoupling protein-2 mRNA by troglitazone in the pancreatic islets of Zucker diabetic fatty rats. Biochem. Biophys. Res. Commun. 1997, 237:359-361.
40. Ravnskjaer K., Boergesen M., Rubi B., et al. Peroxisome proliferator-activated receptor α (PPARα) potentiates, whereas PPARγ attenuates, glucose-stimulated insulin secretion in pancreatic β-cells. Endocrinology 2005, 146:3266-3276.
41. Patanè G., Anello M., Piro S., Vigneri R., Purrello F., Rabuazzo A.M. Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-γ inhibition. Diabetes 2002, 51:2749-2756.
42. Sugden M.C., Holness M.J. Potential role of peroxisome proliferator-activated receptor-α in the modulation of glucose-stimulated insulin secretion. Diabetes 2004, 53(Suppl 1):S71-S81.
43. Unger R.H., Zhou Y.T. Lipotoxicity of β-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001, 50(Suppl 1):S118-S121.
44. Kim H., Haluzik M., Asghar Z., et al. Peroxisome proliferator-activated receptor-α agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis. Diabetes 2003, 52:1770-1778.
45. Poudyal H., Panchal S.K., Diwan V., Brown L. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog. Lipid. Res. 2011, 50:372-387.